CTP parameter mean (95% CI) by marker status in pretreatment and palliative groups combined
| Positive | Negative | P Valuea | |
|---|---|---|---|
| HPV | (n = 5) | (n = 19) | |
| BF | 121.4 (56.8–186.1) | 101.6 (63.5–139.6) | .53 |
| BV | 8.2 (5.1–11.4) | 13.2 (2.4–24.0) | .97 |
| CP | 30.4 (9.8–51.1) | 27.3 (17.4–37.2) | .67 |
| MTT | 7.4 (3.3–11.6) | 7.8 (6.5–9.1) | .52 |
| EGFR | n = 15 | n = 5 | |
| BF | 108.7 (60.5–156.9) | 105.4 (42.5–168.2) | .66 |
| BV | 14.7 (0.8–28.6) | 7.4 (5.4–9.4) | .93 |
| CP | 27.1 (16.7–37.6) | 37.3 (5.4–69.2) | .79 |
| MTT | 7.0 (5.4–8.5) | 7.8 (3.9–11.7) | .22 |
Note:—CI indicates confidence interval.
↵a P value derived from the Wilcoxon 2-sample test.